GLP-1s

Here are 10 stories from Becker's Hospital Review on opioids by state, beginning with the most recent.

The Blue Cross Blue Shield Association released a report July 12 analyzing opioid use disorder diagnosis in relation to prescription rates and opioid usage among BCBS members, where Iowa ranked the fourth-lowest nationwide, according to The Gazette.

Limiting the number of opioids prescribed for one procedure can affect the number of pills prescribed for other procedures, according to a study published in the Journal of the American College of Surgeons.

Drugmaker GlaxoSmithKline entered into a four-year collaboration with 23andMe to use human genetics to guide drug development, investing $300M in the direct-to-consumer genetic testing company to fund the effort, the companies said July 25.

In 2016, more than 500,000 Medicare beneficiaries received high doses of opioids, many of which exceeded drug manufacturers' recommend prescription amount, according to federal data cited by WXYZ Channel 7. 

In a JAMA Surgery-published study of 34,186 surgical patients, 23.1 percent reported preoperative opioid use.

  Ohio physicians are still prescribing too many opioids to residents, despite the implementation of opioid-limiting legislation, according to a new report from The U.S. Department of Health and Human Services.

Ohio will give Elysium Therapeutics $3 million in funding to develop a new class of opioids that cannot be abused, according to The Inquirer.

Researchers at The University of Texas at Austin created an opioid-free painkiller that works by targeting receptors on immune cells, according to a study published July 5 in The Journal of Neuroscience.

Twenty-eight states have created laws and policies limiting the prescription of opioids to patients. For some individuals with chronic pain, these types of restrictions are more crippling than curative, according to NPR.